VitaDAOIn a recent data drop on July 26, 2024, Artan Bio shared significant progress in its innovative…Led by CEO Anthony Schwartz and CSO Michael Torres, Artan Bio focuses on arginine mutations, specifically the CGA codon, common in…Sep 6Sep 6
VitaDAOVitaDAO Receives 21M BIO Tokens for Pioneering DeSciVitaDAO, a leader in decentralized science (DeSci) focusing on longevity research, has been awarded 21 million BIO tokens through Bio…Aug 12Aug 12
VitaDAOVitaDAO Letter: Tokenization of the Artan Bio IP-NFTHappy DeSci Summer, Vitalians! For those new here, VitaDAO is a global community working together to fund groundbreaking longevity…Jun 24Jun 24
VitaDAOUnlocking Research Innovation with IP-NFTs: How to Get Started with Decentralized FundingAuthor: Morgan WeaverJun 23Jun 23
VitaDAOThe Hidden Story of Rapamycin: Insights from Prof. Adam Salmon — The VitaDAO Aging Science PodcastMeet the man who secretly ran the most important rapamycin study you never heard of. In this episode of the Aging Science Podcast I…Jun 18Jun 18
